Skip to main content
Equibles

Squarepoint Ops LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1642575 NEW YORK, NY
Back to ALNY Full portfolio

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$70,440,718
-$70,749,121 QoQ
Shares Held
233,999
-45.2% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#68
of 780 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Derivatives in ALNY

reported options exposure · as of Jun 30, 2026
CallValue
$7,194,617
CallShares
23,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. ALNY ranks #3 (5.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
This page 		233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in ALNY

Export CSV
43 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,194,617 23,900
2026-06-30 $70,440,718 233,999
2026-03-31 $22,863,117 69,100
2026-03-31 $141,189,839 426,723
2026-03-31 $4,102,788 12,400
2025-12-31 $139,562,822 350,969
2025-12-31 $29,068,215 73,100
2025-12-31 $1,471,305 3,700
2025-09-30 $66,377,640 145,565
2025-09-30 $8,162,400 17,900
2025-09-30 $3,876,000 8,500
2025-06-30 $797,616 2,446
2025-06-30 $1,402,187 4,300
2025-06-30 $815,225 2,500
2025-03-31 $1,692,485 6,268
2025-03-31 $567,042 2,100
2025-03-31 $1,296,096 4,800
2024-12-31 $4,306,173 18,300
2024-12-31 $30,048,381 127,697
2024-12-31 $5,482,723 23,300
2024-09-30 $11,744,056 42,701
2024-09-30 $990,108 3,600
2024-09-30 $2,227,743 8,100
2024-06-30 $24,006,942 98,794
2024-06-30 $291,600 1,200
2024-03-31 $2,989,000 20,000
2024-03-31 $2,989,000 20,000
2024-03-31 $86,746,907 580,441
2023-12-31 $64,280,454 335,826
2023-09-30 $42,084,981 237,634
2023-06-30 $31,838,312 167,623
2023-03-31 $26,688,232 133,228
2022-12-31 $524,968 2,209
2022-09-30 $7,556,040 37,750
2022-06-30 $18,245,835 125,100
2022-03-31 $6,113,251 37,438
2021-06-30 $322,088 1,900
2021-03-31 $1,863,708 13,200
2021-03-31 $9,120,874 64,600
2020-12-31 $3,029,340 23,308
2020-09-30 $4,002,689 27,491
2020-06-30 $463,880 3,132
2020-03-31 $1,277,463 11,736

Report a Problem

Category
Description
Email (optional, for follow-up)